Objective: To use a large population-based cohort to determine age-dependent short-term outcomes after pancreatic resection.
P
eople aged 65 years and older account for the fastest growing subset of the United States population. Whereas the number of people under the age of 65 has tripled in the twentieth century, the number of people 65 years or older has increased by eleven times in the same time period. [1] [2] [3] In 1990, people 65 or older comprised 1/25 of the population. By 1994, this increased to 1/8 of the population and by 2030 people over 65 are expected to account for 1/5 of the population. In addition, the eldest elderly, over 85 years of age, are expected to account for 24% of the elderly population and 5% of the overall population by 2050. 1 Etzioni et al have previously described the potential impact of the growing elderly population on the surgical workforce. 4 They examined national discharge and U.S. Census data and predict a 28% increase in General Surgery volume between 2001 and 2020. Advancing age is one of the well-known risk factors for the development of cancer including pancreatic and other periampullary cancers. The annual incidence of pancreatic cancer increases from 2 per 100,000 population in patients 40 -44 years of age to 100 per 100,000 population in patients 80-84-year-old. 5 Therefore, we can expect to see an increasing number of elderly patients presenting with pancreatic cancer in the coming decades.
Over the last decade, outcomes after pancreatic resection have improved with many series reporting in-hospital or 30-day mortality rates of less than 5%. 6 -9 Pancreatic resection still carries significant risk with reported morbidity rates exceeding 30%. 6,7,10 -17 Many surgeons believe that age alone is not a contraindication to pancreatic resection. However, the data are mixed. The age cutoffs for "elderly" vary signifi-cantly among the different studies with some studies using 65 years as a cutoff, some 70 years, and some 80 years. All of these studies are single-institution studies, often with limited number of patients. Few studies have enough patients to stratify them into multiple age groups.
The majority of studies report statistically higher morbidity rates in the designated older patients when compared with younger patients. [11] [12] [13] [14] [15] 18 Some studies show no difference in mortality, 9, [11] [12] [13] 17 whereas other demonstrate higher mortality in the group they define as "older" patients. 14, 15, 19 Likewise, some studies show that survival is the same in the elderly population after pancreatic resection, 11, 12, 14 whereas others demonstrate lower survival rates in elderly patients. 9 The lack of consistency in defining older patients, the single-institution nature of the studies, and the inconsistent findings make the studies difficult to compare and critically evaluate.
The goals of our study were to use a population-based dataset to compare outcomes after pancreatic resection in 4 different age groups of patients to examine trends in mortality, length of stay, and discharge status with increasing age. In addition, we explored the relationship between hospital volume, age, and patient outcomes. We used a multivariate analysis to determine the independent effect of age on outcomes after controlling for other important covariates.
METHODS

Data Source
Data from the Texas Hospital Inpatient Discharge Public Use Data File (PUDF) from the years 1999 through 2005 were used for this study. The data were collected by the Texas Department of State Health Services, Texas State Health Care Information Center (THCIC), Center for Health Statistics to develop administrative reports on the use and quality of hospital care in Texas. 20 The database includes all discharge records for 466 participating nonfederal hospitals in Texas. It has 205 data fields in a base data file and 13 data fields in a detailed charges file. The data include patient demographics, hospital information, lengths of stay, ICD-9 diagnosis codes, ICD-9 procedure codes, hospital day of procedure, hospital charges, payer information, and discharge status.
Study Population/Patient Characteristics
For the years 1999 through 2005, all discharges with a primary procedure code for pancreatic resection (ICD-9 procedure codes, 52.6, 52.7, 52.51, 52.52, 52.53, and 52.59; Table 1 ) were selected. The codes included pancreatic head resection, distal pancreatic resection, total pancreatectomy, and pancreatic resections not otherwise specified. Pancreatic resection for any reason including periampullary adenocarcinoma, chronic pancreatitis, and other benign and malignant diseases of the pancreas were included.
Patients were divided into 4 age groups: Ͻ60 years, 60 -69 years, 70 -79 years, and 80ϩ years. The Texas Hospital Inpatient Discharge PUDF categorizes patients into 5-year age groups and does not provide the actual age. As a result, we do not report mean or median age of the cohort and all the analysis is performed with the categorical age group designations defined above. Bivariate and multivariate analysis analyses (see statistical methods below) were used to determine the effect of age on the outcome variables: (1) in-hospital mortality, (2) discharge status, and (3) length of stay. In-hospital mortality is used because this dataset does not provide 30 day mortality information. Patients surviving the index hospitalization were classified as having been discharged home (with or without home health) or discharged to a nursing facility or other acute inpatient unit. This includes skilled nursing facilities, intermediate nursing facilities, other inpatient acute care hospitals, and Medicare-and Medicaid-certified long-term care hospitals or nursing facilities.
The Texas Health Care Information Center calculates 2 variables for the purpose of risk adjustment, the "risk of mortality" and the "illness severity." This methodology was designed by the 3M Corporation. These are calculated based on the All Patient Defined-Diagnosis Related Grouper (APR-DRG) and consider comorbidity, age, and certain procedures to give a score from 0 to 4, with 4 being the most severe. This methodology has been validated for risk adjustment in a study linking severity of illness to hospital costs. 21 The "illness severity" and "risk of mortality" scores of 0 and 1 were collapsed into a single category because very few patients had illness severity scores of 0.
We also sought to determine the relationship of hospital volume and age in outcomes after pancreatic resection. A Texas hospital was included in the analysis if at least one pancreatic resection was performed there in the 6-year time period. Hospitals were classified into H-V and L-V providers based on the 2004 Leapfrog criteria of Ͼ10 cases per year. 22 Because our study spanned multiple years we used the following criteria to determine hospital volume status: (1) a minimum volume of more than 10 pancreatic resections per year for 4 of the 7 years of the study and (2) an average volume during the 7-year period of Ͼ10 pancreatic resections.
Statistical Analysis
SAS Statistical Software, version 9.1.3 (Cary, N.C.) was used for all statistical analyses. Summary statistics were calculated for the entire cohort of patients. If data were missing in certain categories the reported percentages use the Multivariate logistic regression models were used to assess the independent effect of age on in-hospital mortality and the requirement for ongoing inpatient nursing care at discharge (discharge other than to home). All of our multivariate models controlled for differences in demographic factors, year of operation, hospital volume, procedure type, diagnosis, risk of mortality, illness severity, and admission status (emergent versus elective) among the 4 age groups. The deviance per degree of freedom was used to assess model fit. For logistic regression models we report odds ratios and 95% confidence intervals (CI) relative to a chosen reference group. Type 3 P-values for each factor. Type 3 P-values represent the independent significance of each factor with all other factors already in the model.
RESULTS
Overall Cohort
Between January 1999 and December 2005, 3,736 patients underwent pancreatic resection in Texas. The total number of resections increased from 391 in 1999 to 654 in 2005. Demographic data, diagnoses, admission status, insurance status, procedure type, and number of patients resected at H-V hospitals (Ͼ10 pancreatic resections per year) are shown in Table 2 . Patients were divided into 4 age groups for the analysis. Patients Ͻ60 years of age were 47.7%, 23.7% were 60 -69 years of age, 22.9% were 70 -79 years of age, and 5.7% were 80 or older. Female patients were 51.7%. The age group distribution remained constant over the 7 years of the study (P ϭ 0.58). The majority of patients were white (63.0%) and there was a significant proportion of Hispanic patients (19.1%). The remaining racial distribution is shown in Table 2 .
The indications for pancreatic resection included periampullary cancer (58.0%), chronic pancreatitis (12.8%), and other benign (14.4%) and malignant (14.8%) lesions. Patients who underwent pancreaticoduodenal resection were 68.1%, 25.1% of patients underwent distal pancreatic resection, and 6.8% of patients underwent pancreatectomy not otherwise specified. These operations were elective in 72.3% of patients and urgent or emergent in the remaining 27.7%. Over 90% of patients were insured and 60.6% of patients had their pancreatic resection performed at H-V hospitals.
Mortality/discharge status data were available on 3,723 patients. There were 180 deaths after pancreatic resection for an overall in-hospital mortality rate of 4.8%. The distribution of "illness severity scores" and "risk of mortality" scores for the overall cohort is shown in Table 3 . Both of these variables were positively correlated with mortality. As the scores increased, the mortality rates increased. This is also shown in Table 3 . Of the patients who survived, 90.4% of the patients were discharged to their homes and 9.6% were discharged to 
Demographics, Diagnoses, and Procedure by Age Group
The gender distribution differed by age group, with a higher percentage of female patients in the oldest and youngest groups (P ϭ 0.04) is shown in Table 4 . The percentage of white patients increased with each increasing age comprising only 56.6% of patients Ͻ60-year-old and 74.3% of patients over 80-year-old (P Ͻ 0.0001). Likewise, the number of insured patients increased with each increasing age group (P Ͻ 0.0001), with the distribution shown in Table 4 . This difference was most obvious between the patients Ͻ60-yearold and patients 60-69-year-old, when Medicare coverage begins. With each increasing age group, periampullary cancer was more likely the indication for pancreatic resection, with 76.6% of patients 80 years or older and only 44.1% of patients Ͻ60-year-old having periampullary cancer (P Ͻ 0.0001).
Resection at a H-V hospital was less common as patients got older. Patients Ͻ60 years 62.3%, 61.9% of patients 60 -69 years, 57.4% of patients 70 -79 years, and 53.7% of patients 80 years or older were resected at H-V centers (P ϭ 0.01). However, as the age group increased, older patients were less likely to undergo emergent surgery than their younger counterparts, suggesting more careful selection of these patients. The distribution of procedures by age group is shown in Table 4 . This relationship is complex with more patients in the youngest group undergoing distal pancreatic resection (P Ͻ 0.0001).
The distributions of "risk of mortality" and "severity of illness" scores differed between the age groups (P Ͻ 0.0001 for both scores) and are shown in Figure 1 . For risk of mortality, as age group increased the distribution shifted toward the higher risk groups (Fig. 1A) . The illness severity scores showed a similar, though less striking pattern (Fig. 1B) .
Outcomes by Age Group
In-hospital mortality increased from 2.4% to 5.8% to 7.4% to 11.4% with increasing age group (P Ͻ 0.0001) as is shown in Table 5 . The median length of stay increased with increasing age group, with a median length of stay of 11 days for patients Ͻ60 years (mean ϭ 16.0 Ϯ 15.6 days), 13 days for patients 60 -69 years (mean ϭ 16.5 Ϯ 12.4 days), 14 days for patients 70 -79 years (mean ϭ 17.6 ϩ 13.2 days), and 15 days for patients over 80 (mean ϭ 17.9 Ϯ 12.4 days). Data regarding length of stay include in-hospital mortalities. The . The x-axis shows the age group and the y-axis shows the percentage of patients with a particular score. For each age category, the 4 different color bars add up to 100%. With increasing age, the distribution of scores is shifted toward higher mortality risk. B. This bar graph represents the distribution of "illness severity" score within each age group category. The 4 possible scores are represented by different color bars (1 ϭ black, 2 ϭ gray, 3 ϭ white, and 4 ϭ striped). The x-axis shows the age group and the y-axis shows the percentage of patients with a particular score. For each age category, the 4 different color bars add up to 100%. With increasing age, the distribution of scores is shifted toward illness severity.
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median lengths of stay are unchanged when the mortalities are excluded.
At the time of discharge from the acute care facility performing the pancreatic resection, many patients required ongoing inpatient nursing care. The percentage of patients requiring continued inpatient nursing care either at a skilled nursing facility, intermediate nursing facility, another acute inpatient hospital, or other long-term care facility increased from 3.5% in patients Ͻ60 years, to 6.2% in patients 60 -69 years, to 20.2% in patients 70 -79 years, and to 38.2% in patients older than 80 years. Of the 90.4% patients discharged home, many required home health care. This percentage increased with age from 13.8% of patients Ͻ60 years discharged home to 31.3% of patients 80 or older discharged home ( Table 5) .
The total hospital charges and the ICU charges were compared among the 4 age groups. Median values are shown in Table 5 . The ANOVA was statistically significant for an overall difference in total charges among the 4 groups (P ϭ 0.03). Hospital charges increased with increasing age group for the first 3 groups, then remained relatively constant for the oldest group. For ICU charges, charges increased with each increasing age group and the overall comparison of means was statistically significant (P ϭ 0.009).
Hospital Volume and Age Group
Overall, L-V hospitals had higher mortality rates (7.3% versus 3.2%, P Ͻ 0.0001). Furthermore, the difference in mortality between H-and L-V hospitals was accentuated with each increasing age group (P Ͻ 0.0001). For patients Ͻ60 years, the mortality at L-V hospitals was 3.0% whereas the mortality at H-V hospitals was 2.0%. In the 60 -69 year age group, mortality increased to 9.5% at L-V hospitals and only 3.5% at H-V hospitals. For patients 70 -79 years, mortality increased to 11.4% at L-V hospitals and 4.5% at H-V hospitals. Finally in patients older than 80 years, mortality increased to 14.5% at L-V hospitals and 8.7% at H-V hospitals.
Multivariate Analysis
We used logistic regression models to assess the independent effect of age group on mortality. The final model, shown in Table 6 , controls for gender, race, year of surgery, diagnosis, admission status, "risk of mortality," "illness severity," hospital volume, and procedure type. When compared with patients Ͻ60 years of age, age group was an independent predictor of mortality after pancreatic resection (P ϭ Ͻ0.0001), with patients age 60 -69 being 2.53 times more likely to die (95% CI: 1.53 -4.17), patients age 70 -79 being 1.81 times more likely to die (95% CI: 1.12 -2.93), and patients 80 and older being 4.45 times more likely to die (95% CI: 2.31 -8.57) after pancreatic resection. Whereas gender (P ϭ 0.17), race (P ϭ 0.27), diagnosis (P ϭ 0.07), and admission status (P ϭ 0.06) did not independently predict survival, hospital volume (P ϭ 0.0003), year of diagnosis (P ϭ 0.01), "risk of mortality" score (P Ͻ 0.0001), and procedure type (P ϭ 0.02) were independent predictors of mortality.
A separate logistic regression model was used to evaluate the independent effect of age group on discharge other than to home (including inpatient nursing care either at a skilled nursing facility, intermediate nursing facility, transfer to another acute inpatient hospital, or other long-term care facility). Again, age group was predictive, with patients 60 -69 years being 1.91 times as likely to require continued inpatient care (95% CI: 1.27 -2.87), patients 70 -79 year being 5.61 times as likely to require continued inpatient care (95% CI: 3.95 -7.96), and patients 80 years and older being 16.35 times more likely than patients less than 60-year-old to require continued inpatient care (95% CI: 10.4 -25.7). Hospital volume (P Ͻ 0.0001), year of diagnosis (P ϭ 0.04), "risk of mortality" score (P Ͻ 0.0001), and "illness severity" score (P Ͻ 0.0001) were significant independent predictors as well. The final model is also shown in Table 6 .
DISCUSSION
This report is the first population-based study evaluating the effect of age on short-term outcomes after pancreatic resection. In contrast to previous studies that arbitrarily chose the cutoff to define old or elderly, [11] [12] [13] [14] [15] [16] [17] [18] [19] our study is unique in that it analyzes 4 different age groups enabling us to demonstrate distinct trends with increasing age. To our knowledge, it is the first study to examine the effect of age on whether patients can be discharged home or require continued inpatient nursing care at discharge. In addition, it is the first study of significant size to allow the use of multivariate analysis to assess the independent effect of age on outcomes 
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after pancreatic resection, thereby controlling for multiple covariates which may also influence the same outcomes. Our study shows that increasing age group is a significant independent predictor for mortality after pancreatic resection after controlling for gender, race, year of surgery, diagnosis, admission status, "risk of mortality," "illness severity," hospital volume, and procedure type. The length of stay increased with increasing patient age group. Increasing age independently predicts the requirement for continued in-patient nursing care at discharge from the hospital from less than 4% in patients Ͻ60 years of age to over 38% in patients 80 and older. Likewise, in the patients discharged home, the need for home health care was higher with each increasing age group. Finally, this study demonstrates that with increasing age patients are less likely to be resected at H-V hospitals and that hospital volume disproportionately affects mortality as the age group increases.
With increasing age, ICU charges increased as might be expected. The same pattern was observed with total hospital charges for the first 3 age groups. The similar charges in the last 2 age groups imply careful selection of the most ideal patients in the oldest group. We did not perform a more in-depth economic analysis because we cannot determine readmission rates, charges from readmissions, charges at nursing facilities, or preoperative charges that occurred separate from the admission for surgery. In addition, we have data on hospital charges, but do not have actual cost data.
The observed discrepancies between our populationbased data and many previous studies are likely multifactorial. All previous studies are single-institution studies with some having low numbers of patients. In many of these studies, there mortality rates were higher in the older age groups, but the study was underpowered to demonstrate a statistical difference. 13, 14, 16, 19 For example, Bathe et al retrospectively evaluated a total of 70 patients. Fifty-four were less 65-74-year-old and 16 were 75 years or older. Their older age group had a mortality rate of 25% compared with only 3.7% in the younger group, but this difference was not statistically significant. 14 In addition, the age cutoff in most previous studies varied from 65 to 80 years. Some previous studies do not demonstrate a difference in length of stay. 9, 12, 17 In 2 studies from the same institution, one shows a difference in length of stay 11 whereas the other does not.
12
The latter study was performed 8 years after the first and reported an overall decreased length of stay. The introduction of critical pathways for the care of patients undergoing pancreatic surgery during this time period likely explains the difference between the 2 studies. Our study demonstrates longer lengths of stay as age group increases, as others have reported.
11,14
By multivariate analysis, we found that age was a significant independent predictor of mortality after pancreatic resection. However, when compared with patients Ͻ60-yearold, the odds ratio for in-hospital mortality in patients 60 -69 was lower than the odds ratio for patients 70 -79. We speculate that this may reflect increased aggressiveness with resection of larger tumors and subsequently more complications in younger patients.
We used the "risk of mortality" and "illness severity" scores calculated by the THCIC to control for patient comorbidities. The use of the "risk of mortality" and "illness severity" scores based on the 3M methodology has been validated for risk adjustment in a study linking severity of illness to hospital costs. 21 These scores are further validated in the bivariate analysis in which both "risk of mortality" and "illness severity" scores are strongly positively correlated with in-hospital mortality rates. We did not use a Charlson comorbidity index, 23 commonly used with administrative data, as this index is designed for longitudinal data. Our data represent data from single admissions making the Charlson score invalid for this purpose.
The year of operation was an independent predictor of mortality, with mortality decreasing with each increasing year of diagnosis. As the number of pancreatic resections has increased each year, this finding is likely the result of improved surgical technique, better ICU care and better management of complications with increased experience over the last decade. Conversely, with each increasing year of diagnosis, patients were more likely to require continued inpatient nursing care at discharge. This is not a result of older patients undergoing more pancreatic head resections, having more cancers, or being more severely ill, as the model controls for these factors (and others, see Table 6 ). We hypothesize that more patients are surviving the complications from these procedures. This is reflected in an increasing number of patients being unable to go home secondary to debilitation and increased nursing needs such as wound care, drain care, etc. Many patients who might have died in previous decades may now survive until discharge, but require too much nursing care to be discharged home.
We recognize that our study has several limitations. We are unable to evaluate readmission rates because the public uses the data file that does not provide a unique patient identifier allowing us to link admissions. Similarly, we cannot evaluate long-term survival with this data set. Because we are using administrative data, procedures are well coded, but overall morbidity rates and specific complications such as pancreatic fistula, delayed gastric emptying, and intraabdominal abscess are difficult to identify. Lastly, age is provided in 5-year categories, so we cannot provide mean and median age or evaluate age as a continuous variable.
To our knowledge this is one of the largest studies evaluating the effect of age on short-term outcomes after pancreatic resection. The population-based nature of the study increases generalizability over previous single institution reports. Increased age is an independent risk factor for mortality after pancreatic resection and the inability to be discharged home. Whereas age alone should not be a contraindication to pancreatic resection it is important for surgeons to recognize that older patients had higher inhospital mortality rates, longer lengths of stay, were less likely to be discharged home, and more likely to require care at an inpatient nursing or acute care facility at the time of discharge. Older patients were less likely to be resected at H-V hospitals and our data demonstrate that the effect of hospital volume on mortality is accentuated with increasing age. It will be important to develop algorithms to carefully select elderly patients for these procedures and to maximize referral to H-V centers for elderly patients having pancreatic surgery to optimize their outcomes. Another population-based analysis of long-term survival after pancreatic resection in cancer patients by age group is warranted as is a more in-depth longitudinal economic analysis.
continue as the elderly are more likely to require discharge to extended care facilities or require home health care.
Clearly, the power of such large numbers in your analysis is an advantage compared with the previously published single institution series. Unfortunately, as you point out in your manuscript, there are significant limitations to your analysis. The lack of information related to readmissions does not concern me as much because it is predictable that there will be a higher readmission rate in the elderly.
The biggest question, however, is left unanswered, that is, are the short-term results in these elderly so discouraging that we should rethink whether pancreatic resection is appropriate based on survival? To do this, we need not only long-term survival outcomes, which, at least according to single institution data, would seem comparable at all age groups, but also quality of life data because these patients may never return to their homes.
Without the benefit of a database to answer these questions, I will ask you: Should we be doing pancreaticoduodenectomy for large pancreatic cancers in octogenarians? How about periampullary cancers? How about 4-cm IPMN with nonmalignant cytology? Do you have any data in your analysis that can answer this, or could I at least get a gut reaction to each of these scenarios?
Next, does your database allow you to look at the role of chemotherapy or radiation for pancreatic malignancy, because this is important? Do the elderly experience the benefit of these treatments? I know you are interested in whether patients with pancreatic cancer are actually denied appropriate surgical therapy. Do you have any data as to whether the elderly are being denied therapy solely based on age regardless of the extent of their tumor or comorbidities?
Furthermore, although you showed the majority of patients in Texas have their pancreatic resections in H-V centers, there is a statistically significant and disturbing trend against performing these resections in the elderly at H-V centers. You would think that if any patients were to be referred to H-V centers it would be the elderly. Do you have an explanation for this seemingly illogical practice in the Lone Star State?
Finally, although it preceded your time at Hopkins, for a long time in the early years Dr. Cameron prohibited us from doing Whipple's on patients over the age of 70 years. Does this analysis make him a visionary, or is that policy overcautious? Keep in mind that he is probably the only person to ever perform a Whipple on a 103-year-old patient.
DR. JOHN D. BIRKMEYER (ANN ARBOR, MICHIGAN): After this study, there should be no doubt that the oldest patients do significantly worse after surgery for pancreatic cancer and other serious malignancies. In addition to your data from Texas, a study by our group, published in a 2007 issue of JACS, used national SEER Medicare data to demonstrate that patients over 80 years of age experienced markedly higher rates of 30-day mortality and were much more likely to wind up in SNFs and nursing homes.
We also found that older folks do much, much worse over the long term. For example, 5-year survival after a Whipple operation for pancreatic cancer was less than 5% for people over 80 years with comorbidities. In this context, should we be focusing on where these patients should receive surgery, or whether they should be undergoing surgery in the first place? DR. MICHEAL E. ZENILMAN (BROOKLYN, NEW YORK): The linear increase in mortality rate in elderly patients is a known phenomenon, as is the exponential effect of comorbid illness on both morbidity and mortality. I am a little concerned about how you stratified risk and whether or not true comorbid illnesses-lung, heart, kidney disease, diabetes-were taken into your analysis.
DR. JOE BESSY (NEW YORK, NEW YORK): I have 2 technical questions and a philosophic one.
The first is on selection. If I understand, you selected only for the primary procedure. There must be several procedures, and given the vagaries of coding at different hospitals, I would like to ask whether you selected on all the procedures for pancreatic resection or whether you would have gotten additional patients that might have made the effect bigger or smaller.
The other technical question, what about using age as a continuous variable? What is the odds ratio for every extra year of age in your model?
My final question echoes Dr. Lillemoe's regarding the potential bias of our treatment of the elderly in society. In New York State, patients with multiple traumas, patients with burns, and older patients are less likely to be referred to a trauma center or a burn center. Therefore, what you saw regarding a patient with a pancreatic malignancy is indeed consistent with some others. Why do you think that is? Could it be related to payment or some other reason? DR. TAYLOR S. RIALL (GALVESTON, TEXAS): As Dr. Lillemoe points out; our study has several limitations that we detail in the manuscript. One of the limitations is that age in this Texas Discharge dataset comes in age categories, at five-year intervals. For this reason I could not analyze age as a continuous variable, which answers one of Dr. Bessy's first questions.
The more important limitations, as Dr. Lillemoe mentioned, are related to our inability to look at long-term survival, to follow patients after the index admission, and evaluate readmissions. If you look at the data from the single institution studies, many of them showed no difference in long-term survival. Some, however, demonstrate worse longterm survival in the elderly population. As Dr. Birkmeyer points out, these patients' quality of life is not measured. The fact that many elderly patients may never get discharged home certainly impacts their quality of life.
I feel that pancreatic resection is underutilized in patients with early stage pancreatic cancer; thus, my answer to the question, "Is age alone a contraindication for pancreatic resection?" is "No." I do not want anyone to misunderstand, I do not believe that age alone is a contraindication to pancreatic resection, but, as Dr. Zenilman suggests, this provides guidance in what we can tell our patients to expect. In fact, on Tuesday I will perform a pancreatic resection in an 80-year-old patient. We need to be aware that these patients will have more complications, and, therefore, they may end up with longer recovery times, and are more likely to be discharged to a nursing home, etc.
I think the most striking thing from this data is the difference between the H-and L-V hospitals. I think the real question is not whether they should receive resection, but rather where they should be resected. If you are considering resection in elderly patients, these need to be done at H-V hospitals that show better outcomes.
Why are these elderly patients less likely to go to H-V centers? I think it is multifactorial. We hypothesize that these patients are reluctant to travel. In fact when I deal with many elderly patients they are even reluctant to have the surgery at first and they are certainly reluctant to have it farther away from their home. They are often less able and less willing to travel long distances. In Texas, to get to an H-V center often requires several hours of traveling, unlike in Maryland where nothing is more than 2 hours away.
With regard to the way we adjusted risk, we used 2 variables, the risk of mortality and the severity of illness scores, which were calculated by the Texas Health Care Information Center. These scores use the APR DRG related coding, which takes into account comorbidity, age, and procedure type. We can look at individual comorbidities, but these are not reliably coded so we did not specifically look at them individually. These scores should have taken into account pulmonary disease, cardiac disease, etc., and they certainly correlated with mortality in the bivariate and multivariate analyses.
Is Dr. Cameron a visionary? I trained with Dr. Cameron and I think he is a visionary. Dr. Cameron did not initially perform pancreatic resections in patients over 80, but now he does. I think we need to be aggressive, but smart in selecting who receive resection. Doctors who are not advocates of pancreatic resection criticize the surgical literature because it comes from single institution studies. As a result, I think it is important to present this population-based data and present the real story to help in counseling elderly patients with pancreatic cancer in making this decision.
